We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Sphincter-Sparing Treatment for Anal Fistulas Successful

By HospiMedica International staff writers
Posted on 07 Jun 2012
A novel anal fistula plug combines a synthetic bioabsorbable material with a design engineered to optimize operative success. More...


The Gore BIO-A Fistula Plug features bundled hollow tubes attached to a circular disk, which helps the plug stay in place, reducing the chance of a leading cause of fistula plug failure - the extrusion of the plug through the distal opening of the fistula tract. It also facilitates reproducible anchoring for dependable performance. The three dimensional (3D) structure of the tubes expands to fill the defect and facilitates rapid incorporation, helping to hold the device in place within the fistula. Each tube can be trimmed or removed entirely, so the device conforms for a precise fit.

The Gore BIO-A is constructed from Polyglycolic Acid:Trimethylene Carbonate (PGA:TMC), a synthetic, 100% bioabsorbable material which is backed by 15 years of research and clinical use, and has been successfully used to treat thousands of patients. It provides the patient’s body with a scaffold on which to build new tissue. Over time, as the patient begins to heal, PGA:TMC is gradually absorbed by the body, leaving no permanent material behind. The Gore BIO-A Fistula Plug is a product of Gore Medical (Gore, Flagstaff, AZ, USA), and has been approved by the US Food and Drug Administration (FDA).

“Clinicians have been searching for an alternative to current methods, which have a disappointingly high failure rate,” said Ron Anderson, general surgical products business unit leader at Gore. “The Gore BIO-A Fistula Plug has been engineered to offer a fundamentally new and reliable solution. This new device builds upon Gore’s heritage of innovation, high-performance technology and quality, which have enabled the company to create and bring to market many widely used products for surgical use.”

“Device dislodgement and degradation of the anal fistula plug by bacterial enzymes have accounted for some failures in the treatment of this condition in the past,” said Bradford Sklow, MD, an assistant professor in the department of surgery at the University of Utah School of Medicine (Salt Lake City, USA; www.medicine.utah.edu). “I believe the unique tube configuration of the Gore BIO-A Fistula Plug combined with a synthetic, bioabsorbable material presents an improvement in fistula plug design and may lead to more successful treatment outcomes.”

Anal fistula plugs are intended for the repair of anorectal fistulas, and are often used as a successful alternative to fistulotomy, fistulectomy, and other invasive procedures. Fistula repairs using a plug avoid dividing the sphincter muscles, thereby reducing the risk of incontinence. The fistula plug provides a scaffold for soft tissue repair and facilitates closure of the fistula, but failures can occur due to dislodgment of the plug from the fistula tract.

Related Links:

Gore Medical
University of Utah School of Medicine



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.